Display options
Cite
Fischer S, Bettstetter M, Becher A, et al. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett. 2016;12(1):601-610doi: 10.3892/ol.2016.4668.
Fischer, S., Bettstetter, M., Becher, A., Lessel, M., Bank, C., Krams, M., Becker, I., Hartmann, A., Jagla, W., & Gaumann, A. (2016). Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncology letters, 12(1), 601-610. https://doi.org/10.3892/ol.2016.4668
Fischer, Sonja, et al. "Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination." Oncology letters vol. 12,1 (2016): 601-610. doi: https://doi.org/10.3892/ol.2016.4668
Fischer S, Bettstetter M, Becher A, Lessel M, Bank C, Krams M, Becker I, Hartmann A, Jagla W, Gaumann A. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett. 2016 Jul;12(1):601-610. doi: 10.3892/ol.2016.4668. Epub 2016 Jun 01. PMID: 27347187; PMCID: PMC4907297.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2016 Jul;12(1):601-610. doi: 10.3892/ol.2016.4668. Epub 2016 Jun 01.

Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination.

Oncology letters

Sonja Fischer, Marcus Bettstetter, Andrea Becher, Marlene Lessel, Cyril Bank, Matthias Krams, Ingrid Becker, Arndt Hartmann, Wolfgang Jagla, Andreas Gaumann

Affiliations

  1. Institute of Pathology Kaufbeuren-Ravensburg, D-87600 Kaufbeuren, Germany.
  2. Part Shared Practice Molecular Pathology South Bavaria, D-81675 Munich, Germany.
  3. Institute of Pathology Kaufbeuren-Ravensburg, D-87600 Kaufbeuren, Germany; Part Shared Practice Molecular Pathology South Bavaria, D-81675 Munich, Germany.
  4. Institute of Pathology Rosenheim, D-83022 Rosenheim, Germany.
  5. Institute of Pathology Erlangen, D-91054 Erlangen, Germany.

PMID: 27347187 PMCID: PMC4907297 DOI: 10.3892/ol.2016.4668

Abstract

The aim of the present population-based cohort study was to analyze the association between the prevalence of 32 types of human papilloma virus (HPV) in 615 female patients with abnormal cervical cytopathology findings. In total, 32 HPV types were screened by DNA array technology. HPV infection was detected in 470 women (76.42%), 419 of whom (89.15%) were infected with ≥1 high-risk (HR)-HPV type. HPV16, which is recognized as the main HR-HPV type responsible for the development of cervical cancer, was observed in 32.98% of HPV

Keywords: HPV16; cervical cancer; high-risk HPV; human papilloma virus; squamous intraepithelial lesions

References

  1. J Med Virol. 2010 Nov;82(11):1928-39 - PubMed
  2. J Pathol. 2014 Dec;234(4):441-51 - PubMed
  3. Int J Cancer. 1996 Mar 1;65(5):601-6 - PubMed
  4. Lancet Oncol. 2010 Nov;11(11):1048-56 - PubMed
  5. Open Virol J. 2009 Sep 04;3:60-6 - PubMed
  6. J Infect Dis. 2007 Jun 1;195(11):1582-9 - PubMed
  7. Am J Surg Pathol. 2015 Apr;39(4):496-504 - PubMed
  8. BMC Cancer. 2012 Nov 20;12:533 - PubMed
  9. BMC Infect Dis. 2014 Feb 19;14:87 - PubMed
  10. BMC Infect Dis. 2014 Apr 22;14:214 - PubMed
  11. J Med Virol. 2007 May;79(5):616-25 - PubMed
  12. Am Fam Physician. 2003 Nov 15;68(10):1992-8 - PubMed
  13. BMC Infect Dis. 2013 Jan 30;13:53 - PubMed
  14. J Pathol. 1999 Sep;189(1):12-9 - PubMed
  15. Clin Microbiol Rev. 2003 Jan;16(1):1-17 - PubMed
  16. Vaccine. 2014 Sep 29;32(43):5564-9 - PubMed
  17. J Public Health Res. 2014 Mar 26;3(1):157 - PubMed
  18. N Engl J Med. 2003 Feb 6;348(6):518-27 - PubMed
  19. Virology. 2004 Jun 20;324(1):17-27 - PubMed
  20. Lancet Oncol. 2012 Jan;13(1):89-99 - PubMed
  21. Int J Cancer. 2007 Aug 1;121(3):621-32 - PubMed
  22. JAMA. 2002 Apr 24;287(16):2114-9 - PubMed
  23. Lancet Infect Dis. 2015 May;15(5):565-80 - PubMed
  24. Am J Epidemiol. 2014 Dec 1;180(11):1066-75 - PubMed
  25. J Infect Dis. 2010 Dec 15;202(12):1789-99 - PubMed
  26. Lancet Infect Dis. 2012 Oct;12(10):781-9 - PubMed
  27. Vaccine. 2014 Jan 9;32(3):320-6 - PubMed
  28. Am J Epidemiol. 2013 Aug 15;178(4):625-34 - PubMed
  29. Virology. 2013 Oct;445(1-2):2-10 - PubMed
  30. Am J Epidemiol. 2014 Dec 1;180(11):1076-81 - PubMed
  31. J Clin Oncol. 2015 Mar 10;33(8):964-5 - PubMed
  32. J Natl Cancer Inst. 1993 Jun 16;85(12):958-64 - PubMed
  33. Lancet Oncol. 2012 Jan;13(1):100-10 - PubMed
  34. PLoS One. 2013 Nov 14;8(11):e79372 - PubMed
  35. Lancet. 2009 Jul 25;374(9686):301-14 - PubMed
  36. Br J Cancer. 2003 Jan 13;88(1):63-73 - PubMed
  37. Infect Agent Cancer. 2009 Jun 01;4:8 - PubMed
  38. N Engl J Med. 2007 May 10;356(19):1915-27 - PubMed
  39. J Clin Pathol. 2002 Apr;55(4):244-65 - PubMed
  40. Lancet. 2005 Sep 17-23;366(9490):991-8 - PubMed
  41. Lancet. 2007 Jun 30;369(9580):2161-70 - PubMed
  42. J Infect Dis. 2011 Apr 1;203(7):891-3 - PubMed
  43. J Eur Acad Dermatol Venereol. 2013 Dec;27(12):1527-34 - PubMed
  44. J Clin Invest. 2006 May;116(5):1167-73 - PubMed
  45. J Gen Virol. 2011 Oct;92(Pt 10):2428-36 - PubMed

Publication Types